Abcam PLC (LSE:ABC) - Share price - Overview

Stock Report

Abcam PLC ABC

Last Price
GBX1,312.00

Day Change
-13.00|-0.98%

As of 15/02/2019
18:28:43 GMT | GBX
Minimum 15 Minutes Delay.

Last Close1,325.00p
Day Range1,307.00 - 1,323.00
Mkt Cap2.70Bil
52-Wk Range1,006.00 - 1,588.00
Yield %0.82
ISINGB00B6774699
Volume585,609
P/E43.44
P/S0.12
P/CF0.43

Share Price

Total Returns 15/02/2019

 Chg (%)  
More ...
Abcam PLC7.01 
FTSE 100 TR GBP5.30
 
Financials
201620172018
More ...
Income Statement
Turnover171.67217.10233.20
Operating Profit46.3255.1068.80
Net Profit37.4342.4062.20
Reported EPS18.5320.7030.20
Balance Sheet
Current Assets119.65143.50159.90
Non Current Assets209.91218.20254.90
Total Assets329.56361.70414.80
Current Liabilities33.2932.6049.00
Total Liabilities68.3754.6063.10
Total Equity261.19307.10351.70
Cash Flow
Operating Cash Flow56.7976.5072.90
Net Change in Cash10.4015.705.00

Regulatory News

DateSourceHeadline
More ...
05/02/2019|11:34RNSABCAM PLC - Total Voting Rights
08/01/2019|07:00RNSABCAM PLC - Half Year Trading Update
03/01/2019|13:45RNSABCAM PLC - Total Voting Rights
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
06/12/2018PurchaseDr. Jonathan Simon Milner1,060.00187,7901,990,574.00
30/11/2018DGavin Hilary James Wood1,154.0012138.00
30/11/2018DMr. Alan Thomas Hirzel1,154.0045519.00
08/11/2018Transfer inMr. Alan Thomas Hirzel0.0059,8820.00

Company Profile

Abcam PLC is a biotechnology company engaged in developing antibodies for life science research and clinical communities. It works on regulatory molecules and proteins in biological pathways to treat diseases like cancer and immune deficiency disorders.

Sector

Biotechnology

Index

FTSE AIM UK 50 ,FTSE AIM 100 ,FTSE AIM All-Share

Next Event 04/03/2019

Half-Yearly Results
Ratios
Comp
More ...
PER (E)43.94
Div Yld (E)0.90
PEG (E)0.00
ROCE18.89
Op Mrgn0.30
EPS Grwth0.46
Dividends
PreviousLatest
More ...
Record Date16/03/1809/11/18
Ex-Div15/03/1808/11/18
Paid12/04/1830/11/18
Amnt3.428.58
Directors
More ...
Executive Director, Chief Financial OfficerGavin Hilary James Wood
Executive Director, Chief Executive OfficerMr. Alan Thomas Hirzel
Non-Executive Director, Deputy ChairmanDr. Jonathan Simon Milner
Non-Executive DirectorLady Louise Alexandra Virginia Charlotte Patten of Wincanton
Non-Executive DirectorMs. Mara Glickman Aspinall
Non-Executive DirectorSusan Elizabeth Harris
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.